Prabha Karnachi

416 citations

12 papers · 310 indexed · h-index 10

Co-authors: Robert H. Scannevin Kenneth J. Rhodes Sharon L. Burke Matthew Tudor Elizabeth Joshi Robert P. Sheridan Frank K. Brown Stuart L. Emanuel
Topics: Protease and Inhibitor Mechanisms (5 papers)Peptidase Inhibition and Analysis (4 papers)Computational Drug Discovery Methods (3 papers)
Cited by: Computational Theory and Mathematics Oncology Cancer Research
Journals: Journal of Chemical Information and Modeling Bioorganic & Medicinal Chemistry Letters SLAS DISCOVERY
Partner nations: United States United Kingdom

In The Last Decade

Prabha Karnachi

12 papers receiving 306 citations

Peers

Countries citing papers authored by Prabha Karnachi

Since Specialization

Citations

This map shows the geographic impact of Prabha Karnachi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prabha Karnachi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prabha Karnachi more than expected).

Fields of papers citing papers by Prabha Karnachi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prabha Karnachi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prabha Karnachi. The network helps show where Prabha Karnachi may publish in the future.

Co-authorship network of co-authors of Prabha Karnachi

This figure shows the co-authorship network connecting the top 25 collaborators of Prabha Karnachi. A scholar is included among the top collaborators of Prabha Karnachi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prabha Karnachi. Prabha Karnachi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Prediction Accuracy of Production ADMET Models as a Function of Version: Activity Cliffs Rule 2022 ·Journal of Chemical Information and Modeling ·Robert P. Sheridan,J. Chris Culberson,Elizabeth Joshi,Matthew Tudor,Prabha Karnachi	15
2	Experimental Error, Kurtosis, Activity Cliffs, and Methodology: What Limits the Predictivity of Quantitative Structure–Activity Relationship Models? 2020 ·Journal of Chemical Information and Modeling ·Robert P. Sheridan,Prabha Karnachi,Matthew Tudor,Yuting Xu,Andy Liaw,Falgun Shah,Alan C. Cheng,Elizabeth Joshi,Meir Glick,Juan C. Alvarez	43
3	Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development 2013 ·ACS Medicinal Chemistry Letters ·Zhuming Zhang,Xin‐Jie Chu,Jinjun Liu,Qingjie Ding,Jing Zhang,David Bartkovitz,Nan Jiang,Prabha Karnachi,Sung‐Sau So,Christian Tovar,Zoran Filipovic,Brian Higgins,Kelli Glenn,Kathryn Packman,Lyubomir T. Vassilev,Bradford Graves	68
4	Discovery of novel Cobactin-T based matrix metalloproteinase inhibitors via a ring closing metathesis strategy 2011 ·Bioorganic & Medicinal Chemistry Letters ·Lawrence J. Wilson,Bingbing Wang,(unknown),Robert H. Scannevin,Sharon L. Burke,Prabha Karnachi,Kenneth J. Rhodes,William V. Murray	7
5	A novel 5-[1,3,4-oxadiazol-2-yl]-N-aryl-4,6-pyrimidine diamine having dual EGFR/HER2 kinase activity: Design, synthesis, and biological activity 2008 ·Bioorganic & Medicinal Chemistry Letters ·Terry V. Hughes,Guozhang Xu,Steven K. Wetter,Peter J. Connolly,Stuart L. Emanuel,Prabha Karnachi,Scott R. Pollack,Niranjan B. Pandey,Mary Adams,(unknown),Steven A. Middleton,Lee M. Greenberger	24
6	7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors: Design, synthesis, and biological activity 2008 ·Bioorganic & Medicinal Chemistry Letters ·Terry V. Hughes,Stuart L. Emanuel,(unknown),Peter J. Connolly,Catherine A. Rugg,Angel R. Fuentes‐Pesquera,Prabha Karnachi,Richard Alexander,Steven A. Middleton	16
7	β-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: Part 1. Design, synthesis, and lead identification 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Robert H. Scannevin,Bingbing Wang,Sharon L. Burke,Lawrence J. Wilson,Prabha Karnachi,Kenneth J. Rhodes,Bharat Lagu,William V. Murray	24
8	1-Hydroxy-2-pyridinone-based MMP inhibitors: Synthesis and biological evaluation for the treatment of ischemic stroke 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yuemei Zhang,(unknown),(unknown),Bangping Xiang,Robert H. Scannevin,Zhihong Huang,Jianya Ma,Sharon L. Burke,Prabha Karnachi,Kenneth J. Rhodes,Paul Jackson	32
9	β-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: Part 2. Optimization of α-amino substituents 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Robert H. Scannevin,Bingbing Wang,Sharon L. Burke,Zhihong Huang,Prabha Karnachi,Lawrence J. Wilson,Kenneth J. Rhodes,Bharat Lagu,William V. Murray	19
10	4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: Synthesis and biological evaluation 2007 ·Bioorganic & Medicinal Chemistry Letters ·Terry V. Hughes,Stuart L. Emanuel,(unknown),Steven K. Wetter,Peter J. Connolly,Prabha Karnachi,Michael Reuman,(unknown),Angel R. Fuentes‐Pesquera,Robert H. Gruninger,Steven A. Middleton,Ronghui Lin,Jeremy Davis,David Moffat	40
11	Synthesis and SAR of α-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Yuemei Zhang,(unknown),Bangping Xiang,(unknown),Robert H. Scannevin,Sharon L. Burke,Prabha Karnachi,Kenneth J. Rhodes,Paul Jackson	9
12	Practical Approaches to Efficient Screening: Information-Rich Screening Protocol 2004 ·SLAS DISCOVERY ·Prabha Karnachi,Frank K. Brown	13

About Prabha Karnachi

Prabha Karnachi is a scholar working on Cancer Research, Oncology and Computational Theory and Mathematics, having authored 12 papers that have together received 310 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (5 papers), Peptidase Inhibition and Analysis (4 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Computational Theory and Mathematics (90 citations), Oncology (123 citations) and Cancer Research (65 citations). Prabha Karnachi has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Robert H. Scannevin, Kenneth J. Rhodes, Sharon L. Burke, Matthew Tudor, Elizabeth Joshi, Robert P. Sheridan, Frank K. Brown, Stuart L. Emanuel, Terry V. Hughes and Peter J. Connolly. Their work appears in journals such as Journal of Chemical Information and Modeling, Bioorganic & Medicinal Chemistry Letters and SLAS DISCOVERY.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact